Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience has informed BSE that its Board of Directors will meet on Friday, May 30, 2025 at 6:00 PM at the registered office in Hyderabad. The main agenda is to consider and approve the audited financial results for the fourth quarter and full financial year ending March 31, 2025, along with noting the auditors' report on these results. The company has also confirmed that the trading window for designated persons is closed from April 1, 2025 to June 1, 2025 under its Insider Trading Policy. No financial figures, guidance, or outcomes have been disclosed in this notice as the results are yet to be approved by the Board.
This is a standard regulatory intimation and does not by itself move the stock. Investors should wait for the actual audited results to be published after the May 30 meeting to understand the company's full-year performance and any key takeaways from the auditors' report.